Literature DB >> 573173

Cutaneous angiosarcoma of the head and neck.

D J Hodgkinson, E H Soule, J E Woods.   

Abstract

Between 1920 and 1970, 13 patients (7 men and 6 women) with cutaneous angiosarcomas of the head or neck were treated at the Mayo Clinic; the mean age of the patients was 66 years. Three clinical patterns were noted: a superficial spreading type, a nodular type, and an ulcerating type. There were no predisposing benign lesions; however, in one patient, angiosarcoma developed in an area of previously irradiated skin. Three modes of therapy were used: surgery alone, radiation alone, and surgery with postoperative irradiation. Of the 13 patients, 2 survived more than 5 years and 2 were alive within 1 year of therapy. Because cervical lymph node spread is common, lymph node clearance is recommended for patients with lateralized lesion or with palpable lymphadenopathy at presentation.

Entities:  

Mesh:

Year:  1979        PMID: 573173     DOI: 10.1002/1097-0142(197909)44:3<1106::aid-cncr2820440345>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Sinonasal tract angiosarcoma: a clinicopathologic and immunophenotypic study of 10 cases with a review of the literature.

Authors:  Brenda L Nelson; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2007-10-25

2.  Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma.

Authors:  Yuki Honda; Atsushi Otsuka; Sachiko Ono; Yosuke Yamamoto; Judith A Seidel; Satoshi Morita; Masahiro Hirata; Tatsuki R Kataoka; Tatsuya Takenouchi; Kazuyasu Fujii; Takuro Kanekura; Yuko Okubo; Kenzo Takahashi; Teruki Yanagi; Daichi Hoshina; Hiroo Hata; Riichiro Abe; Taku Fujimura; Takeru Funakoshi; Koji Yoshino; Mamiko Masuzawa; Yasuyuki Amoh; Ryota Tanaka; Yasuhiro Fujisawa; Tetsuya Honda; Kenji Kabashima
Journal:  Oncoimmunology       Date:  2016-11-04       Impact factor: 8.110

3.  Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients.

Authors:  K Ogawa; K Takahashi; Y Asato; Y Yamamoto; K Taira; S Matori; S Iraha; N Yagi; A Yogi; S Haranaga; J Fujita; H Uezato; S Murayama
Journal:  Br J Radiol       Date:  2012-07-17       Impact factor: 3.039

4.  Single institutional experience of the treatment of angiosarcoma of the face and scalp.

Authors:  Y Miki; T Tada; R Kamo; M N Hosono; H Tamiya; Y Shimatani; S Tsutsumi; R Ogino; Y Miki
Journal:  Br J Radiol       Date:  2013-10       Impact factor: 3.039

5.  Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan.

Authors:  Takamichi Ito; Hiroshi Uchi; Takeshi Nakahara; Gaku Tsuji; Yoshinao Oda; Akihito Hagihara; Masutaka Furue
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-25       Impact factor: 4.553

6.  Irradiation-induced penile angiosarcoma.

Authors:  R J Prescott; A R Mainwaring
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

7.  Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature.

Authors:  Ping Yang; Qi Zhu; Fuqiang Jiang
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

8.  Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.

Authors:  B Ashleigh Guadagnolo; Gunar K Zagars; Dejka Araujo; Vinod Ravi; Thomas D Shellenberger; Erich M Sturgis
Journal:  Head Neck       Date:  2010-10-19       Impact factor: 3.147

9.  Angiosarcoma of the of scalp with calvarium involvement in a 50-year-old African-American man.

Authors:  Michael K Obeng; Ambrosia Hernandez; Amer Dastgir; Patrick A Adegboyega; Paul Salinas; Dennis C Gore
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

10.  Intracranial invasion from recurrent angiosarcoma of the scalp.

Authors:  Kyu-Sun Choi; Hyung-Joon Chun; Hyeong-Joong Yi; Jeong-Tae Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.